Zhejiang Gongdong Medical Technology Co.Ltd(605369) : Zhejiang Gongdong Medical Technology Co.Ltd(605369) : shareholder return plan for the next three years (20222024)

Zhejiang Gongdong Medical Technology Co.Ltd(605369) : Zhejiang Gongdong Medical Technology Co.Ltd(605369) : the shareholder return plan for the next three years (20222024) according to the provisions and requirements of relevant documents such as the notice on matters related to the further implementation of cash dividends of listed companies and the regulatory guidelines for listed companies No. 3 – cash dividends of listed companies issued by China Securities Regulatory Commission, Zhejiang Gongdong Medical Technology Co.Ltd(605369) (hereinafter referred to as “the company”) pays attention to its own development and actively rewards investors, In order to further establish and improve a scientific, sustainable, stable and transparent shareholder return mechanism, the board of directors of the company, in combination with the actual situation of the company, hereby formulates the company’s shareholder return plan for the next three years (20222024). The specific contents are as follows: 1. The considerations for the formulation of shareholder return plan are the long-term and sustainable development of the company; Shareholders’ requirements and wishes; The actual situation of the company’s operation and development; Social capital cost, external financing environment, etc. The company comprehensively analyzes the above factors and makes institutional arrangements for dividend distribution. 2. The formulation principle of shareholder return planning is based on the profit distribution policy stipulated in the articles of association. On the basis of the company’s financial stability, the company’s profit distribution should focus on the reasonable return on investment to shareholders